A. Lurkin
A. Lurkin publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, on topics such as Sarcoma Diagnosis and Treatment, Clinical practice guidelines implementation and Global Cancer Incidence and Screening.
- World rank
- #1,247,728 of 7,710,434 ranked researchers
- Rank in France
- #57,156 of 324,115
- Works
- 29
- Citations
- 1.5k
- Citations per work
- 50.7
What does A. Lurkin research?
A. Lurkin's work is mostly in Medicine (57%), Economics, Econometrics and Finance (11%), Health Professions (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1963.8%
- Medicine1756.9%
- Health Professions26.9%
- Everything else725.1%
- Social Sciences311.1%
- 1Oncology21% of their works
- 2Pulmonary and Respiratory Medicine17% of their works
- 3Public Health, Environmental and Occupational Health12% of their works
- 4Economics and Econometrics11% of their works
- 5General Health Professions7% of their works
- 6Surgery7% of their works
Research topics
- Sarcoma Diagnosis and Treatment
- Clinical practice guidelines implementation
- Global Cancer Incidence and Screening
- Economic and Financial Impacts of Cancer
- Colorectal and Anal Carcinomas
- Gastrointestinal Tumor Research and Treatment
- Colorectal Cancer Surgical Treatments
- Health Systems, Economic Evaluations, Quality of Life
Which keywords describe A. Lurkin's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Prognostic Factors, Osteosarcoma, Soft Tissue Sarcoma, Clinical Guidelines, Guideline Development and Quality of Life.
- Sunitinib
- Preoperative Chemoradiotherapy
- Health Utility Measures
- Chemoradiation
- Mortality Rates
- Cost of Care
- Quality of Life
- Clinical Guidelines
- Osteosarcoma
- Clinical Practice Guidelines
- Chemotherapy
- Prognostic Factors
- Soft Tissue Sarcoma
- Guideline Development
- Cancer Incidence
- Financial Toxicity
- Anal Cancer
- Cost-effectiveness Analysis
- Imatinib Mesylate
- Rectal Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy132 topics
- Clinical Practice Guidelines122 topics
- Prognostic Factors122 topics
- Osteosarcoma91 topic
- Soft Tissue Sarcoma91 topic
- Clinical Guidelines81 topic
- Guideline Development81 topic
- Quality of Life72 topics
- Cancer Incidence51 topic
- Cost of Care51 topic
- Financial Toxicity51 topic
- Mortality Rates51 topic
- Anal Cancer41 topic
- Chemoradiation41 topic
- Cost-effectiveness Analysis31 topic
- Health Utility Measures31 topic
- Imatinib Mesylate31 topic
- Preoperative Chemoradiotherapy31 topic
- Rectal Cancer31 topic
- Sunitinib31 topic
Where does A. Lurkin work?
A. Lurkin's main affiliation in the publication record is Centre Léon Bérard, France.
How many publications and citations does A. Lurkin have?
OpenAlex counts 29 works and 1,471 citations for A. Lurkin, an h-index of 12, ranking #1,247,728 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about A. Lurkin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.